Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Boston MA, Hartford CT, Philadelphia PA, Rochester NY,
Sponsor: University of Iowa
Sex: All
Age: 0+
Code: NCT01193088
Recruiting
Early Intervention in High Risk CCUS
for
Clonal Cytopenia of Undetermined Significance, Cytopenia
Location: Boston MA
Sponsor: Lachelle D. Weeks, MD, PhD
Sex: All
Age: 18+
Code: NCT06802146
Early Phase 1, Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for
HER2-positive Breast Cancer, Breast Cancer
Location: Boston MA, Scarborough ME, New York NY, Camillus NY,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07102381
Phase 2, Recruiting
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Boston MA, Rochester NY, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 65+
Code: NCT06042569
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
for
Extensive Stage Small Cell Lung Cancer
Location: Boston MA, New York NY, Philadelphia PA, Pittsburgh PA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037758
Phase 1, Recruiting
Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, DuBois PA, London,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Phase 4, Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Location: Boston MA, New Haven CT, Durham NC, Chicago IL,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT06116110
Recruiting
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
for
Respiratory Distress Syndrome, Pre-term Infants
Location: Boston MA, Valhalla NY, The Bronx NY, New York NY,
Sponsor: Aerogen Pharma Limited
Sex: All
Age: 0
Code: NCT06776783
Phase 3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, New Haven CT, The Bronx NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase 3, Recruiting
Outpatient Epcoritamab in Large B-cell Lymphoma
for
Relapsed Large B-cell Lymphoma,
Location: Boston MA, Newton MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06811272
Phase 2, Recruiting
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
for
Lymphocytic Leukemia, Chronic, SLL
Location: Boston MA, Durham NC
Sponsor: Catapult Therapeutics
Sex: All
Age: 18+
Code: NCT04704323
Phase 1, Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, Maspeth NY, New York NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07185009
Phase 3, Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)